Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Gain Therapeutics, Inc. is a biotechnology company developing small molecule therapeutics targeting protein misfolding and dysfunction across neurodegenerative, lysosomal storage, metabolic, and oncology diseases. Utilizing its Magellan® platform, it identifies allosteric binding sites to create highly specific, brain-penetrant drugs. Its pipeline includes candidates for Parkinson’s disease and other neurodegenerative disorders, focusing on restoring enzyme function and addressing unmet medical needs through innovative, mechanism-based therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.